Abstract
Apoptosis, the programmed cell death, is a highly organized process essential for elimination of degenerated cells. Therefore, a tremendous effort is put into the development of new cancer therapeutics, which induce apoptosis in tumor cells. The integration of novel computer-based strategies, which accelerate this development, is a challenging goal. In this context, a variety of terphenyl-based compounds that mimic the alpha-helical region of the pro-apoptotic Bak BH3 domain has already been identified.
These compounds were used as lead compounds for an in silico screening in our database which contains more than four million drug-like molecules. During this screening, the compounds from the virtual database were compared with the lead compounds by 2D and 3D similarities. After additional property filtering and docking experiments, five promising candidates have been validated in vitro experiments to strengthen the in silico results.
Keywords: Apoptosis, Bcl-2, Bak, In silico screening, Molecular docking, BH3-helix, Programmed Cell Death, Degenerated Cell, Membarane Blebbing, DNA Degradation, Fragmentation of Nucleaus, Intrinsic pathway, Extrinic pathway, Death Inducing Lignands, Receptors, Permeabilization
Letters in Drug Design & Discovery
Title: In Silico Identification of Small Molecule Mimetics of the Pro-Apoptotic BH3-Helix
Volume: 8 Issue: 4
Author(s): Melanie Fullbeck, Julia Hossbach, Ines S. Jaeger, Peter T. Daniel and Robert Preissner
Affiliation:
Keywords: Apoptosis, Bcl-2, Bak, In silico screening, Molecular docking, BH3-helix, Programmed Cell Death, Degenerated Cell, Membarane Blebbing, DNA Degradation, Fragmentation of Nucleaus, Intrinsic pathway, Extrinic pathway, Death Inducing Lignands, Receptors, Permeabilization
Abstract: Apoptosis, the programmed cell death, is a highly organized process essential for elimination of degenerated cells. Therefore, a tremendous effort is put into the development of new cancer therapeutics, which induce apoptosis in tumor cells. The integration of novel computer-based strategies, which accelerate this development, is a challenging goal. In this context, a variety of terphenyl-based compounds that mimic the alpha-helical region of the pro-apoptotic Bak BH3 domain has already been identified.
These compounds were used as lead compounds for an in silico screening in our database which contains more than four million drug-like molecules. During this screening, the compounds from the virtual database were compared with the lead compounds by 2D and 3D similarities. After additional property filtering and docking experiments, five promising candidates have been validated in vitro experiments to strengthen the in silico results.
Export Options
About this article
Cite this article as:
Fullbeck Melanie, Hossbach Julia, S. Jaeger Ines, T. Daniel Peter and Preissner Robert, In Silico Identification of Small Molecule Mimetics of the Pro-Apoptotic BH3-Helix, Letters in Drug Design & Discovery 2011; 8 (4) . https://dx.doi.org/10.2174/157018011794839484
DOI https://dx.doi.org/10.2174/157018011794839484 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Biological Evaluation of the Salicylamide and Salicylic Acid Derivatives as Anti-Estrogen Agents
Medicinal Chemistry Bile Acids as Novel Pharmacological Agents: The Interplay Between Gene Polymorphisms, Epigenetic Factors and Drug Response
Current Pharmaceutical Design Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery Editorial (Thematic Issue: Signal Transduction of Natural Products for Anticancer Therapy)
Current Signal Transduction Therapy The Renaissance of the 68Ge/68Ga Radionuclide Generator Initiates New Developments in 68Ga Radiopharmaceutical Chemistry
Current Topics in Medicinal Chemistry Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)
Current Topics in Medicinal Chemistry TRIM65 in White Matter Lesions, Innate Immunity, and Tumor
Current Molecular Pharmacology Review: The JAK/STAT Protein Activation – Role in Cancer Development and Targeted Therapy
Current Signal Transduction Therapy Is There Anybody in There? On The Mechanisms of Wall Crossing of Cell Penetrating Peptides
Current Protein & Peptide Science The Effect of Protein Restriction in the In Vitro Metabolism of Albendazole in Rats
Drug Metabolism Letters Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component
Current Pharmaceutical Design Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry Somatostatin and its Analogs
Current Drug Targets Immune Responses to Lentiviral Vectors
Current Gene Therapy Salmonella as Live Trojan Horse for Vaccine Development and Cancer Gene Therapy
Current Gene Therapy Implication of Aberrant Glycosylation in Cancer and Use of Lectin for Cancer Biomarker Discovery
Protein & Peptide Letters Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design Interaction between the Anticancer Drug Cisplatin and the Copper Chaperone Atox1 in Human Melanoma Cells
Protein & Peptide Letters Estrogen and Female Lower Urinary Tract Dysfunction
Current Women`s Health Reviews Recent Patents on Proteases and Kinases as Anti-Infective Agents: A Review
Recent Patents on Anti-Infective Drug Discovery